RheumNow/LinkedIn
Jan 11, 2026, 09:58
Exploring the Role of Antiphospholipid Antibodies in Severe Preeclampsia – RheumNow
RheumNow shared a post on LinkedIn about a paper by Beatriz Grand et al. published in Lupus:
“100 women w/ severe preeclampsia (PE) compared to 40 pregnant controls. antiphospholipid antibodies (aPL) was significantly more prevalent in PE women (34% vs 10%) [OR = 4.63]. aPL positivity was also linked to both early and late severe PE [OR = 4-5, p = .008].”
Title: Exploring the association between preeclampsia and antiphospholipid antibodies. A prospective study
Authors: Beatriz Grand, Sebastián Udry, Andrea Avigliano, Mónica González Alcántara, José Omar Latino, Liliana Susana Voto
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 21, 2026, 17:57Ula Sankowska: What I’ll Bring to ASRM INNOVATE in Baltimore
-
Oct 21, 2026, 17:40Robert Borowczyk: The Invisible Waiting Room
-
Oct 21, 2026, 17:35Fereshteh Safian: Behind the Scenes of Reproductive Medicine
-
Oct 21, 2026, 17:20The Relationship Between Trophectoderm Biopsy and Early Pregnancy Outcomes – RBMO
-
Oct 21, 2026, 17:09Jules McDonald: The Future of Fertility Is Happening in Abu Dhabi
-
Oct 21, 2026, 16:53Ashley Evans: I Never Imagined I’d Be a Fertility Story with a Group of People Whom I Have Never Met…
-
Oct 21, 2026, 16:41Karthik Raj: Asherman’s Syndrome – When the Endometrium Cannot Regenerate Normally
-
Oct 21, 2026, 16:36Katy Encalade: A Few Misconceptions I Think Every Woman Considering Egg Donation Deserves to Understand
-
Oct 21, 2026, 16:21The FeRGI Working Group 2026-2027 – ESHRE SIG Reproductive Genetics